Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Current Protocols in Pharmacology|December 14, 2016
Detection of Receptor Heteromerization Using In Situ Proximity Ligation AssayIvone Gomes, Salvador Sierra, Lakshmi A DeviJournal of Neurochemistry|June 23, 2011
Potentiation of μ-opioid receptor-mediated signaling by ketamineAchla Gupta, Lakshmi A Devi, Ivone GomesPharmacology Research & Perspectives|November 10, 2020
Diversity of molecular targets and signaling pathways for CBDDouglas L de Almeida, Lakshmi A DeviBehavioural Pharmacology|March 14, 2020
The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin testEsad Ulker, Wisam Toma, Alyssa White, et al.Neuropharmacology|February 16, 2019
MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in ratsDiana V Atigari, Rajendra Uprety, Gavril W Pasternak, et al.The AAPS Journal|April 6, 2006
Targeting opioid receptor heterodimers: strategies for screening and drug developmentAchla Gupta, Fabien M Décaillot, Lakshmi A DeviACS Chemical Neuroscience|February 7, 2019
Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and RegulationSeshat M Mack, Ivone Gomes, Lakshmi A DeviJournal of Medicinal Chemistry|November 10, 2020
Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl TemplateAbdelfattah Faouzi, Rajendra Uprety, Ivone Gomes, et al.Frontiers in Pharmacology|December 19, 2014
Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and functionIvone Gomes, Achla Gupta, Ittai Bushlin, et al.Progress in Molecular Biology and Translational Science|October 21, 2018
Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric DisordersLindsay M Lueptow, Lakshmi A Devi, Amanda K FakiraPageof 22